SKVI — Skinvisible Income Statement
0.000.00%
Last trade - 00:00
- $3.86m
- $10.06m
- $0.02m
- 34
- 14
- 81
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.043 | 0.276 | 0.663 | 0.279 | 0.02 |
Cost of Revenue | |||||
Gross Profit | 0.026 | 0.276 | 0.66 | 0.274 | 0.02 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.831 | 0.529 | 0.366 | 0.373 | 0.51 |
Operating Profit | -0.788 | -0.254 | 0.298 | -0.094 | -0.49 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.7 | -1.45 | -1.07 | -1.22 | -2.38 |
Net Income After Taxes | -1.7 | -1.45 | -1.07 | -1.22 | -2.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.7 | -1.45 | -1.07 | -1.22 | -2.38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.7 | -1.45 | -1.07 | -1.22 | -2.38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.508 | -0.322 | -0.26 | -0.302 | -0.525 |